Inactivation of the Hippo pathway has also been associated with elevated expression of Par-3 in metastatic prostate cancer by driving a KIBRA/Par-3/aPKC complex formation in lieu of the activating KIBRA/Merlin/FRMD6 complex [52]. This evidence concerns the gene WWC1 and metastatic prostate carcinoma.